Plasticity in binding confers selectivity in ligand induced protein degradation

[1]  Dennis L. Buckley,et al.  A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader. , 2017, Cell chemical biology.

[2]  C. Crews,et al.  Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead. , 2017, Cell chemical biology.

[3]  C. Crews,et al.  Targeted protein knockdown using small molecule degraders. , 2017, Current opinion in chemical biology.

[4]  Christopher J. Ott,et al.  BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment. , 2017, Molecular cell.

[5]  Michael B. Stadler,et al.  pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase , 2017, Nature Communications.

[6]  S. Armstrong,et al.  Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands. , 2017, Angewandte Chemie.

[7]  D. Lamont,et al.  Structural basis of PROTAC cooperative recognition for selective protein degradation , 2017, Nature chemical biology.

[8]  J. Bradner,et al.  Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck , 2016, Cancer.

[9]  Chin-Chun Lu,et al.  A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase , 2016, Nature.

[10]  C. Crews,et al.  PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer , 2016, Proceedings of the National Academy of Sciences.

[11]  G. Pelosi,et al.  Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628. , 2016, Cancer discovery.

[12]  G. Petzold,et al.  Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase , 2016, Nature.

[13]  M. Eck,et al.  SPLINTS: small-molecule protein ligand interface stabilizers. , 2016, Current opinion in structural biology.

[14]  W. I. Mohamed,et al.  Cullin–RING ubiquitin E3 ligase regulation by the COP9 signalosome , 2016, Nature.

[15]  C. Crews,et al.  Small-Molecule PROTACS: New Approaches to Protein Degradation. , 2016, Angewandte Chemie.

[16]  Eunhwa Ko,et al.  Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL. , 2016, Angewandte Chemie.

[17]  Dennis L. Buckley,et al.  Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging. , 2015, Angewandte Chemie.

[18]  I. E. Smith,et al.  Catalytic in vivo protein knockdown by small-molecule PROTACs. , 2015, Nature chemical biology.

[19]  I. E. Smith,et al.  HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. , 2015, ACS chemical biology.

[20]  Dennis L. Buckley,et al.  Selective Target Protein Degradation via Phthalimide Conjugation , 2015 .

[21]  C. Crews,et al.  Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. , 2015, Chemistry & biology.

[22]  S. Carr,et al.  Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS , 2015, Nature.

[23]  A. Ciulli,et al.  Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4 , 2015, ACS chemical biology.

[24]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[25]  H. Handa,et al.  Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs , 2014, Nature Structural &Molecular Biology.

[26]  Jeremy L. Jenkins,et al.  Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide , 2014, Nature.

[27]  Edward L. Huttlin,et al.  MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes , 2014, Analytical chemistry.

[28]  Christopher J. Ott,et al.  The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins , 2014, Science.

[29]  S. Carr,et al.  Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells , 2014, Science.

[30]  H. Handa,et al.  Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN , 2013, British journal of haematology.

[31]  Piotr Sliz,et al.  Collaboration gets the most out of software , 2013, eLife.

[32]  Chad J. Miller,et al.  A comprehensive mathematical model for three-body binding equilibria. , 2013, Journal of the American Chemical Society.

[33]  W. L. Jorgensen,et al.  Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α. , 2012, Angewandte Chemie.

[34]  A. Gingras,et al.  Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family , 2012, Cell.

[35]  P. Zwart,et al.  Towards automated crystallographic structure refinement with phenix.refine , 2012, Acta crystallographica. Section D, Biological crystallography.

[36]  B. Zakeri,et al.  Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin , 2012, Proceedings of the National Academy of Sciences.

[37]  S. Lowe,et al.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.

[38]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[39]  Jeffrey J. Gray,et al.  A generalized approach to sampling backbone conformations with RosettaDock for CAPRI rounds 13–19 , 2010, Proteins.

[40]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[41]  Toshihiko Ogura,et al.  Identification of a Primary Target of Thalidomide Teratogenicity , 2010, Science.

[42]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[43]  Paul D Adams,et al.  Electronic Reprint Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow ): a Tool for Ligand Coordinate and Restraint Generation Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow): a Tool for Ligand Coordinate and Restraint Gener , 2022 .

[44]  D. Moras,et al.  A set of baculovirus transfer vectors for screening of affinity tags and parallel expression strategies. , 2009, Analytical biochemistry.

[45]  John Kuriyan,et al.  The origin of protein interactions and allostery in colocalization , 2007, Nature.

[46]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[47]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[48]  Naveeda Qadir,et al.  Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization measurements. , 2005, Assay and drug development technologies.

[49]  R. Deshaies,et al.  Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  B. Druker,et al.  Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. , 2000, The Journal of pharmacology and experimental therapeutics.

[51]  Ballard,et al.  Overview of the CCP 4 suite and current developments , 2022 .